Carlos Juan - Concepedia

Author

Carlos Juan

Hospital Universitario Son Espases ORCID

Also Known As

C. Juan, Carlos Juan, Carlos Juan Nicolau, Martínez Martínez, Luis

110

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Son Espases Research Institute of Health Sciences Hospital Universitario Son Dureta Health Research Institute of the Balearic Islands Universitat de les Illes Balears

About

Carlos Juan is an author at Hospital Universitario Son Espases specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	31	2.5K
2	Health Sciences	18	21	1.9K
3	Biochemistry	4	4	395
4	Natural Sciences	1	1	165
5	Biology	1	1	102

Carlos Juan

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein Bartolomé Moyá, Andreas Dötsch, Carlos Juan, PLoS Pathogens	2009	285
Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC Gabriel Cabot, Sebastian Bruchmann, Xavier Mulet, Antimicrobial Agents and Chemotherapy Molecular BiologyAntimicrobial ChemotherapyAntibiotic ResistanceBacterial PathogensDrug Resistance	2014	239
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones Gabriel Cabot, Alain A. Ocampo-Sosa, M.Á. Domínguez, Antimicrobial Agents and Chemotherapy GeneticsAntibiotic ResistanceDrug ResistanceResistance Mutation (Virology)Genetic Markers	2012	221
Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates Gabriel Cabot, Laura Zamorano, Bartolomé Moyá, Antimicrobial Agents and Chemotherapy	2016	205
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa Pablo A. Fraile-Ribot, Gabriel Cabot, Xavier Mulet, Journal of Antimicrobial Chemotherapy	2017	199
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in <i>Pseudomonas aeruginosa</i> Isolates from Spanish Hospitals Olivia Gutiérrez, Carlos Juan, Emilia Cercenado, Antimicrobial Agents and Chemotherapy Molecular EpidemiologyEscherichia ColiAntibiotic ResistanceBacterial PathogensDrug Resistance	2007	183
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem Elena Riera, Gabriel Cabot, Xavier Mulet, Journal of Antimicrobial Chemotherapy	2011	180
Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2 Jesús Oteo, Karol Diestra, Carlos Juan, International Journal of Antimicrobial Agents St10 Complex/aMedicineBacteriologySpain BelongPathogen Characterization	2009	176
Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in<i>Pseudomonas aeruginosa</i>Clinical Strains Carlos Juan, María D. Macià, Olivia Gutiérrez, Antimicrobial Agents and Chemotherapy GeneticsBacteriologyMolecular BiologyAntibiotic ResistanceBacterial Pathogens	2005	167
Stepwise Upregulation of the<i>Pseudomonas aeruginosa</i>Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD Homologues Carlos Juan, Bartolomé Moyá, José Luis Pérez, Antimicrobial Agents and Chemotherapy BacteriologyMolecular BiologyProtein AmpdAntibiotic ResistanceBacterial Pathogens	2006	165

Page 1